Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 911.88 billion. The enterprise value is 871.68 billion.

Market Cap	911.88B
Enterprise Value	871.68B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Mankind Pharma has 412.58 million shares outstanding. The number of shares has increased by 0.20% in one year.

Current Share Class	n/a
Shares Outstanding	412.58M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	57.75%
Owned by Institutions (%)	16.89%
Float	105.88M

Valuation Ratios

The trailing PE ratio is 43.50 and the forward PE ratio is 41.11. Mankind Pharma's PEG ratio is 2.40.

PE Ratio	43.50
Forward PE	41.11
PS Ratio	7.61
PB Ratio	8.38
P/TBV Ratio	10.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.40

Enterprise Valuation

EV / Earnings	42.70
EV / Sales	7.49
EV / EBITDA	29.95
EV / EBIT	35.30
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	0.17
Debt / FCF	n/a
Interest Coverage	10.10

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.29%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	5.96M
Profits Per Employee	1.04M
Employee Count	19,540
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.12%
50-Day Moving Average	2,497.38
200-Day Moving Average	2,441.69
Relative Strength Index (RSI)	34.50
Average Volume (20 Days)	698,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 116.41 billion and earned 20.41 billion in profits. Earnings per share was 50.81.

Revenue	116.41B
Gross Profit	81.70B
Operating Income	24.57B
Pretax Income	25.86B
Net Income	20.41B
EBITDA	28.93B
EBIT	24.57B
Earnings Per Share (EPS)	50.81

Balance Sheet

The company has 47.27 billion in cash and 4.82 billion in debt, giving a net cash position of 42.45 billion or 102.88 per share.

Cash & Cash Equivalents	47.27B
Total Debt	4.82B
Net Cash	42.45B
Net Cash Per Share	102.88
Equity (Book Value)	107.89B
Book Value Per Share	263.72
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 70.18%, with operating and profit margins of 21.11% and 17.54%.

Gross Margin	70.18%
Operating Margin	21.11%
Pretax Margin	22.21%
Profit Margin	17.54%
EBITDA Margin	24.85%
EBIT Margin	21.11%
FCF Margin	n/a

Dividends & Yields

Mankind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	-0.20%
Earnings Yield	2.24%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a